Signal transduction in esophageal and LES circular muscle contraction. by Harnett, K. M. et al.
YALE JOURNAL OF BIOLOGY AND MEDICINE 72 (1999), pp. 153-168.
Copyright © 2000. All rights reserved.
Signal Transduction in Esophageal and LES
Circular Muscle Contraction
Karen M. Harnett, Weibiao Cao, Nayoung Kim, Uy Dong Sohn,
Harlan Rich, Jose Behar, and Piero Biancania
Department ofMedicine, Rhode Island Hospital and Brown University, Providence,
Rhode Island
Contraction of normal esophageal circular muscle (ESO) in response to acetylcholine (ACh) is
linked to M2 muscarinic receptors activating at least three intracellularphospholipases, i.e., phos-
phatidylcholine-specific phospholipase C (PC-PLC), phospholipase D (PLD), and the high molec-
ular weight (85 kDa) cytosolic phospholipase A2 (cPL42) to induce phosphatidylcholine (PC)
metabolism, production ofdiacylglycerol (DAG) and arachidonic acid (AA), resulting in activation
ofaprotein kinase C (PKC)-dependentpathway.
In contrast, lower esophageal sphincter (LES) contraction induced by maximally effective doses of
ACh is mediatedby muscarinic M3 receptors, linked topertussis toxin-insensitive GTP-bindingpro-
teins ofthe G /,, type. They activate phospholipase C, which hydrolyzes phosphatidylinositol bis-
phosphate (PIP2), producing inositol 1, 4, 5-trisphosphate (IP3) and DAG. IP3 causes release of
intracellular Ca++ andformation ofa Ca++-calmodulin complex, resulting in activation ofmyosin
light chain kinase and contraction through a calmodulin-dependent pathway.
Signal transduction pathways responsiblefor maintenance ofLES tone are quite distinctfrom those
activated during contraction in response to maximally effective doses of agonists (e.g., ACh).
Resting LES tone is associated with activity ofa low molecular weight (-14 kDa) pancreatic-like
(group I) secreted phospholipase A2 (sPLA2) and production ofarachidonic acid (AA), which is
metabolized to prostaglandins and thromboxanes. These AA metabolites act on receptors linked to
G-proteins to induce activation ofPl- and PC-specific phospholipases, andproduction ofsecond
messengers. Resting LES tone is associated with submaximal PIhydrolysis resulting in submaximal
levels ofinositol trisphosphate (IP3)-induced Ca++ release, and interaction with DAG to activate
PKC.
In an animal model ofacute esophagitis, acid-induced inflammation alters the contractilepathway
ofESO and LES. In LES circular muscle, after induction ofexperimental esophagitis, basal levels
ofP1 hydrolysis are substantially reduced and intracellular Ca++ stores arefunctionally damaged,
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resulting in a reduction ofresting tone. The reduction in intracellular Ca++ release causes a switch
in the signal transduction pathway mediating contraction in response to ACh. In the normal LES,
ACh causes release of Ca++ from intracellular stores and activation of a calmodulin-dependent
pathway. After esophagitis, ACh-induced contraction depends on influx of extracellular Ca++,
which is insufficient to activate calmodulin, and contraction is mediated by a PKC-dependentpath-
way. These changes are reproduced in normal LES cells by thapsigargin-induced depletion ofCa++
stores, suggesting thatthe amount ofCa++ availablefor releasefrom intracellular stores defines the
signal transduction pathway activated by a maximally effective dose ofACh.
INTRODUCTION
Disorders of esophageal motor func-
tion and lower esophageal sphincter
(LES)b competence affect more than one
in ten adults over 40 years of age and one
in four adults over 60. Knowledge of the
mechanisms responsible for esophageal
contraction and LES tone may be useful to
understand normal function and some of
the changes associated with esophageal
disease.
The esophagus is relaxed at rest and
contracts with a peristaltic contraction
upon swallowing, propelling the food
bolus from the pharynx into the stomach,
whereas the LES is spontaneously con-
tracted, and relaxes in a timely way when
the esophagus contracts, to allow passage
of the bolus. The swallow-induced con-
traction of the esophagus is mediated by
the neurotransmitter acetylcholine (ACh).
The tonic contraction ofthe LES is due to
specialized myogenic mechanisms, which
may be modulated by inhibitory non-
adrenergic-non-cholinergic (NANC) and
by excitatory cholinergic neural pathways.
The present review describes the cellular
basis forACh-induced ESO and LES con-
traction and spontaneous LES tone and
how inflammation induced by acid or by
reflux ofgastric contents affects the signal
transduction mechanisms mediating con-
traction ofthese smooth muscles.
A smooth muscle esophagus is pre-
sent in marsupials, felines, and primates.
We have used the cat to study esophageal
and lower esophageal sphincter function
and have occasionally obtained normal
esophageal/LES muscle specimens from
human organ donors. We observed that
because of similarities of signal transduc-
tion mechanisms with the human esopha-
gus, th;e cat is a reasonable model for the
study of signal transduction in esophageal
and LES circular muscle.
We have examined normal animals
and two experimental models ofesophagi-
tis. An acute model of experimental
esophagitis (AE) was obtained by
esophageal perfusion with 0.1 N HCl for
45 min on three successive days, with
experiments carried out on the fourth day
[1-5].
More chronic models ofexperimental
esophagitis (CE) were obtained by per-
forming a myotomy of the LES circular
muscle and allowing esophageal inflam-
mation to develop over the course of six
months (six-month CE) or 12 to 14
months (one-year CE) [6-9]. In the 6-
month CE model we find that inflamma-
tion-induced changes in mucosal histol-
ogy and in contractile mechanisms are
similar to the acute model and reversible
by treatment with acid suppressants [8].
Histologic and mechanical changes were
more pronounced in the acute model, sup-
porting this as a reasonable model for the
study of inflammation-induced distur-
bances of esophageal and LES motor
function.
ACh-induced contraction ofESO and
LES circular muscle depends on distinct
intracellular pathways beginning with the
muscarinic receptors acted upon by the
neurotransmitter, extending to the G-pro-
teins, phospholipases, second messen-Harnett et al.: Signal transduction in LES and esophagus 155
gers, and effector mechanisms mediating
muscle contraction. We will review sepa-
rately the signal transduction pathways
responsible for contraction of ESO and
LES and for maintenance of LES tone in
normal animals and in the two experimen-
tal models of esophagitis.
CONTRACTION OF NORMAL
ESOPHAGEAL CIRCULAR
MUSCLE
Esophageal contraction in response to
ACh is mediated by M2 muscarinic recep-
tors since ACh-induced contraction is
selectively inhibited by the M2 muscarinic
antagonist methoctramine. We have exam-
ined the G-proteins linked to muscarinic
and other receptors in the contractile path-
way of ESO [10-12] by examining the
effect of selective G-protein antibodies on
contraction. Our data suggest that M2
muscarinic receptors are linked mostly to
Gi3 because ACh-induced contraction of
permeable cells is inhibited by antibodies
against the a-subunit of GO3, but not by
antibodies against the a-subunit ofGq, Go
or Gi1/2 (Figure 1).
G-proteins are linked to phospholi-
pases, which generate intracellular second
messengers from membrane phospho-
lipids. ACh-induced contraction ofESO is
inhibited by selective inhibitors or anti-
bodies of phosphatidylcholine-specific
phospholipase C (PC-PLC), PLD, and
cPLA2 suggesting, a link betweenGO3 and
these phospholipases [10, 11].
PLA2 preferentially hydrolyzes phos-
pholipids containing arachidonic acid
(AA) in the sn-2 position (most often
phosphatidylcholine), producing AA and
lysophospholipid [13, 14]. PC-PLC
hydrolyzes phosphatidylcholine at the sn3
position, producing diacylglycerol (DAG)
and phosphocholine [15-17]. PLD also
hydrolyzes phosphatidylcholine at the sn3
position, producing choline and phospha-
tidic acid (PA). PA may act as a second
messenger or may be dephosphorylated to
DAG by a phosphatidic acid phosphohy-
drolase [16-20].
Activation ofphospholipases PC-PLC
and PLD results in production of DAG
[21, 22], and activation ofcPLA2 produces
AA [23]. In the normal esophagus AA
causes little contraction by itself but
potentiates contraction induced by the
PKC agonist DAG. DAG and AA act syn-
ergistically to activate protein kinase C
[23]. ACh-induced contraction and activa-
tion of phospholipase requires influx of
extr4cellular Ca++ because ACh-induced
contraction and DAG production decrease
with decreasing extracellular Ca++ levels.
However, activation of PKC by DAG is
Ca++-independent because DAG-induced
contraction does not significantly change
when extracellular or cytosolic Ca++ is
reduced to zero [24]. These data suggest
that the influx of extracellular Ca++ is
required only to activate the phospholipas-
es, and once the second messengers are
produced contraction proceeds by the acti-
vation of a Ca++-independent PKC [22].
We have examined the PKC isozymes
present in ESO and found fll, y, and £
PKC isozymes [25]. However, when ESO
is stimulated by ACh only the Ca++-inde-
pendent £ isozyme translocates from the
cytosol to the membrane, suggesting that
PKCe is involved in agonist-induced con-
traction ofESO. This view is supported by
the findings that PKCe antibodies and
isozyme-selective pseudosubstrates inhibit
ACh-induced contraction ofESO [25].
To conclude, in normal ESO ACh-
induced contraction is mediated by activa-
tion ofM2 muscarinic receptors coupled to
Gi3 type G-proteins. G-protein activation
of PC-PLC, PLD and cPLA2 phospholi-
pases results in phosphatidylcholine
hydrolysis and production of the second
messengers DAG and AA. DAG and AA
synergistically activate a Ca++-indepen-
dent PKCe and produce a PKC-dependent
contraction.156 Harnett et al.: Signal transduction in LES and esophagus
ESOPHAGEAL CONTRACTION IN
MODELS OF ESOPHAGITIS
Acute esophagitis.
In vivo esophageal contraction in
response to swallowing and in vitro
response to electrical stimulation are
antagonized by atropine, suggesting the
involvement ofcholinergic excitatory neu-
rons. After induction of acute experimen-
tal esophagitis by repeated acid perfusion,
contraction inresponse to KCI and toACh,
which act directly on the muscle, is not
affected [1, 2]. However, the in vivo
response to swallowing and the in vitro
response to electrical, i.e., neural stimula-
tion, are significantly reduced. These data
suggest that after acid perfusion
esophageal muscle is still capable of con-
traction, but that the cholinergic neural
mechanisms responsible for release of
excitatory neurotransmitters may be
affected.
Intestinal inflammation in man [26]
and animals [27] has been reported to
result in changes in motility caused by
alterations in enteric nerve and muscle.
Pro-inflammatory cytokines present in
inflammatory sites, such as interleukin-l1
(ILl,B), have been shown to alter muscle
contractility by suppressing the release of
neurotransmitters ACh and norepinephrine
[28, 29].
We examined the effect ofpro-inflam-
matory cytokines on normal esophageal
smooth muscle function. We find that in
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Figure 1. In the normal esophagus, ACh-induced contraction is mediated by M2 mus-
carinic receptors linked to a pertussis toxin-sensitive GTP-binding protein of the G13
type and results in activation of at least three phospholipases acting on membrane
phospholipids [10]. Phosphatidylcholine-specific phospholipase C (PC-PLC) and phos-
pholipase D (PLD) hydrolyze phosphatidylcholine (PC) to produce diacylglycerol (DAG).
Cytosolic phospholipase A2 (cPLA2) is also activated, resulting in production of arachidon-
ic acid (AA) [23]. Activation ofthese phospholipases requires the presence of Ca++ [22, 24],
which is provided by the influx of extracellular Ca++ through voltage-dependent channels
[50], possibly augmented by release of Ca++ from stores. Once DAG is produced, the Ca++-
independent protein kinase Ce (PKCe) is activated, and contraction proceeds through a
calmodulin-independent pathway [24]. AA, produced by PLA2, which is also Ca++-depen-
dent, potentiates the DAG-induced activation of PKC [23]. Acute esophagitis (AE) modifies
ACh signaling in the esophageal circular smooth muscle: a group I secreted PLA (sPLA2)
produces AA, which is metabolized by lipoxygenase (lipoxy) to leukotrienes (LT), which
contribute to activation of PKC [3].Harnett etal.: Signal transduction in LES and esophagus 157
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Figure 2. Resting LES tone is associated with spontaneous activity of phos-
phatidylinositol-specific phospholipase C (P1-PLC) [53] and phosphatidyicholine-
specific phospholipase C (PC-PLC) [21] resulting in production of inositol 1,4,5-
trisphosphate (IP3) and diacyiglycerol (DAG) [21] and activation of a Ca ~-sensitive
protein kinase Cj3S (PKC,B) [25]. A low molecular weight (14 kDA) secreted, pancreatic-
like (group 1) phospholipase A2 (sPLA2) may play a role resting LES tone by producing
arachidonic acid (AA), which is then metabolized to prostaglandins (PG) and thrombox-
anes (TX). PG and TX are membrane permeable and bind to specific G-protein-linked
receptors, to cause activation of Pl-PLC and PC-PLC, producing second messengers and
contraction [57].
normal esophageal muscle IL-iIp and IL-6
cause a significant reduction in contraction
in response to electrical stimulation but
has no effect on ACh-induced contraction.
In contrast, IL-8 and tissue necrosis factor
a (TNFa) do not effect either the response
to ACh or the response to electrical stimu-
lation, but inhibit both responses at higher
concentrations [30]. These results suggest
that IL-1, and IL-6, but not IL-8 orTNFa
inhibit the release of excitatory neuro-
transmitter in response to electrical stimu-
lation without affecting the ability of the
muscle to contract in response to ACh,
and, thus, mimic the changes observed in
our model ofacute experimental esophagi-
tis. The data also suggest thatACh release
from the in vitro esophageal strips in
response to electrical stimulation may be
reduced after induction of acute experi-
mental esophagitis and that this reduction
may be caused by inflammatory cytokines
such as IL-13 and IL-6.
In addition, induction ofAE modifies
ACh-induced signaling (Figure 1). In nor-
mal esophageal muscle a high molecular
weight (85 kDa) (group IV) cytosolic
phospholipase A2 (cPLA2) participates in
acetylcholine-induced contraction of
esophageal circular smooth muscle [23].
Since PLA2, arachidonic acid, and its
metabolites are involved in inflammatory
responses, we examined their role in
esophageal smooth muscle cells (ESO)
isolated by enzymatic digestion from the
circular layer of normal and esophagitis
animals.158 Harnett et al.: Signal transduction in LES and esophagus
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Figure 3. Membrane phospholipids are acted upon by phospholipases A2, a family of
enzymes that catalyze the hydrolysis of glycerolphospholipids at the sn-2 position,
producing free fatty acids and lysophospholipids [13, 14, 58]. PLA2s are divided into
two major classes, intracellular or cytosolic (high molecular weight, 80-85 kDa) cPLA2, and
secretory or secreted (low molecular weight, 14 kDa) cPLA2. The intracellular cPLA2s
include the 85 kDa calcium-sensitive cPLA2, and the 80 kDa calcium-insensitive cPLA2.
The sPLA2 s are divided into different Groups (i.e., 1,11,111, V, VII, VII, IX) according to their
molecular structure and the localization of their disulfide bridges [13, 14, 58, 59, 80].
Mammalian PLA2 enzymes produce arachidonic acid (AA), an important regulator of spe-
cific cellular processes, and precursor to biologically active lipids including prostaglandins,
leukotrienes, thromboxanes and prostacyclins.
After induction of experimental
esophagitis, AA is produced by the same
cPLA2 and, in addition, a second pathway
is activated in response to ACh (Figure 1).
ACh causes activation of a low molecular
weight (14 kDa) group I-secreted PLA2
(sPLA2). After induction of AE, ACh-
induced contraction is significantly inhib-
ited by the sPLA2 antagonists AM5 and
MJ33. The lipoxygenase inhibitor nordi-
hydro-guaiaretic acid (NDGA) and the
leukotriene D4 (LTD4) antagonist ICI
198,615 inhibits ACh-induced contraction
of esophagitis ESO, suggesting that the
AA produced by this sPLA2 may be
metabolized by lipoxygenase to
leukotrienes (LT). Peptido-leukotriene
(LTC4, LTD4, LTE4) content is higher
level in esophagitis than in normal circular
esophageal muscle, and increases in
response to ACh in esophagitis but not in
normal esophageal muscle [3].Harnett et al.: Signal transduction in LES and esophagus 159
The same changes are observed in the
one-year CE model [6]. These data suggest
that in inflammation-free controls AA is
produced by cPLA2 and not by sPLA2 and
is metabolized by cycloxygenase, and not
by lipoxygenase. In AE and CE, activation
of sPLA2 causes additional production of
AA that is metabolized by lipoxygenase to
produce leukotrienes, which contribute to
ACh-induced contraction.
Production ofIL-lp by inflammatory
or target cells may explain some of these
changes in esophageal circular muscle. IL-
1B has been shown to cause activation of
secreted PLA2 and of 5-lipoxygenase in
several experimental preparations [31-39],
and subsequent production ifIL-6 [40-46].
LESTONE
The LES circular muscle is a major
determinant ofLES tone. Although the rel-
ative neurogenic contribution may vary
with the animal species, a significant com-
ponent of tone is thought to be myogenic,
as it is not affected by neural antagonists,
including tetrodotoxin. Functionally, this
muscle is specialized, with muscle strips
from this region developing higher total
and active forces than esophageal strips
[47-49]. This distinctive contractility may
be, at least in part, related to the ability of
the LES muscle to handle Ca++ differently
than esophageal circular muscle [50, 51].
LES muscle maintains tension in a Ca++-
free environment for some time after
esophageal strips are no longer capable of
contraction in response to field stimulation
or high concentrations of acetylcholine.
These findings suggest that LES mus-
cle can use Ca++, released from intracellu-
lar storage sites, to maintain tonic contrac-
tion, and they are consistent with the his-
tology and biochemistry of these muscles.
The LES circular muscle has more abun-
dant endoplasmic reticulum than the
esophageal circular muscle [52].
We have reported that LES tone is
associated with spontaneous, low-level
activity of phospholipase C, resulting in
production of submaximal concentrations
of DAG and inositol trisphosphate (1P3),
which causes release of Ca++ from stores
(Figure 2). The elevated concentrations of
1P3 and DAG, present in LES smooth mus-
cle in the absence of stimulation, decrease
when the LES relaxes in response to VIP
[2, 21]. Increased 'P3 turnover, resulting in
spontaneously elevated 'P3 levels and
steady Ca++ release from storage sites,
may be responsible for LES tonic contrac-
tion. In addition, concurrent activity of a
PC-PLC in the LES contributes to the pro-
duction of additional DAG [21, 53]. 'P3
and DAG, in turn, activate PKC [25]. IP3
and DAG, produced at submaximal levels,
act synergistically; their interaction
depends on Ca++ release and is mediated
through the Ca++-sensitive PKC,B isozyme
[25, 53].
Since G-proteins are linked to phos-
pholipases, we examined the G-proteins
present in the LES. We find, by Western
Blot analysis, that Gq, GD3, and Gil12 are
present in LES circular muscle [11] and
that these G-proteins are spontaneously
active, i.e., bound to GTP, in the absence
of exogenously added excitatory neuro-
transmitters. In unstimulated LES smooth
muscle, [35S]GTPyS binding to GC3, Gil/2,
and Gq antibodies is higher than in ESO
smooth muscle, suggesting that these G-
protein may be activated. Spontaneous
activation of G-proteins may provide the
spontaneous activation of the phospholi-
pases required to maintain threshold levels
of IP3 and DAG, which, in turn, activate a
PKC-dependent tone.
Evidence from our laboratory sug-
gests that production ofAA by a low mol-
ecular weight (14 kDa) group I-secreted
PLA2 [54-55] may contribute to mainte-
nance of LES tone by producing AA
metabolites, such as prostaglandin-F2x or
thromboxanes, which maintain activation
ofG-proteins [56-57] (Figure 2).
Phospholipases A2 are a growing
family of enzymes that catalyze the160 Harnett et al.: Signal transduction in LES and esophagus
hydrolysis of glycerolphospholipids at the
sn-2 position, producing free fatty acids
and lysophospholipids (Figure 3) [13, 14,
58]. PLA2s are divided into two major
classes, intracellular or cytosolic (high
molecular weight, 80-85 kDa) group IV
cPLA2, and secretory or secreted (low
molecular weight, -14 kDa) sPLA2.
The sPLA2s are divided into different
groups (i.e., I, II, III, V, VII, VIII, IX)
according to their molecular structure and
the localization of their disulfide bridges
[59]. Many sPLA2 s function extracellular-
ly, but some have also been localized with-
in mitochondria [60, 61].
LES tone may be mediated by the
activity of a group I (secreted) sPLA2
because: 1) unstimulated LES circular
smooth muscle has higher AA levels than
ESO and spontaneously releases more AA
than ESO smooth muscle; 2) MJ33, a
selective inhibitor of group I sPLA2, sig-
nificantly reduces AA content and sponta-
neous tone of LES circular muscle strips,
whereas the group II sPLA2 antagonist
MJ45 and the cPLA2 inhibitor AACOCF3
has no effect on LES tone; 3) cobra venom
(group I) sPLA2, but not rattlesnake
(group II) orbee venom (group III) sPLA2,
causes dose-dependent contraction ofLES
strips [56].
These data suggest that AA produc-
tion, through group I sPLA2, participates
in maintenance of LES tone. It is possible
that the selectivity ofthe group I sPLA2 in
LES muscle may be conferred by the spe-
cific interaction ofsPLA2 with cell surface
receptors. Specific membrane receptors
for neuronal (N)-type and muscle (M)-
type sPLA2s, have been identified with
snake venom sPLA2 [62-67]. One of these
sPLA2 receptors, the 180 kDa muscle M-
type, has been cloned in rabbit [66] and
man [68] and has been shown to have very
high affinity for mammalian sPLA2.
Receptor binding of sPLA2 is thought to
mediate some of the physiological effects
of mammalian sPLA2, including vascular
smooth muscle contraction, cell prolifera-
tion, and internalization of sPLA2 [69-71].
For example, antigen stimulation results in
the selective binding ofgroup I sPLA2 and
release of AA from bone marrow mast
cells, which have been shown to contain
the mRNA for the group I PLA2 receptor
[72].
The AA produced by sPLA2 in the
LES is metabolized to prostaglandins,
such as PGF2a and thromboxanes which,
in turn contribute to maintaining tone
because the cycloxygenase inhibitors
indomethacin and aspirin, and not the
lipoxygenase inhibitor NDGA, dose-
dependently reduce LES tone. We find that
PGF2a content is significantly higher in
LES than in ESO and that PGF2ax dose-
dependently contracts LES strips and sin-
gle cells. Thromboxanes A2 and B2 may
also be involved in LES tone, since throm-
boxane B2 dose-dependently contracts
LES strips and the thromboxane A2 antag-
onist SQ29548 dose-dependently reduces
LES tone [56, 57]. Whether otherproducts
of AA metabolism are present and play a
role in maintenance of LES tone remains
to be determined.
The AA metabolites PGF2a and
thromboxanes A2/B2 may maintain tone
by binding to their respective receptors
which are coupled to G-proteins. PGF2a
and the thromboxane A2 analog U46619
significantly increases the [35S]GTPyS
binding ofGO3, and Gq in solubilized LES
circular muscle membranes. In addition,
[35S]GTPyS binding in LES circular
smooth muscle is significantly reduced by
indomethacin, suggesting that G-proteins
are activated by cycloxygenase-dependent
production ofAA metabolites [57]. These
data suggest the following hypothesis:
Spontaneous activation of a group I
sPLA2 causes production of AA, and AA
metabolites such as PGF2a and thrombox-
anes, which maintain activation of G-pro-
teins such as GD3, Gi1l2, and Gq. These G-
proteins activate phospholipases such as
phosphatidylinositol-specific phospholi-
pase C (PI-PLC) and PC-PLC, which, inHarnett et al.: Signal transduction in LES and esophagus 161
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Figure 4. Contraction of LES cells by a maximally effective dose of ACh is mediated
by activation of phosphatidylinositol-specific phospholipase C (PI-PLC), and pro-
duction of inositol 1,4,5-trisphosphate (IP3) [10] and diacylglycerol (DAG). IP3 caus-
es release of Ca++ from stores at a concentration sufficient to cause activation of calmod-
ulin (CAM) [53]. Ca++-CAM causes activation of myosin light chain kinase (MLC kinase)
and inhibition of protein kinase C (PKC), inducing a contraction that is entirely calmodulin-
dependent [81]. Ca++-CAM-induced inhibition of PKC masks the presence of other factors
that would otherwise contribute to activation of PKC.
turn, produce DAG and 'P3. DAG and 1P3
synergistically activate PKC. The origin of
the sPLA2 remains to be found, however
preliminary Western Blot studies using
monoclonal antibodies against pancreatic
(i.e., group I) human sPLA2 indicate that a
pancreatic-like sPLA2 is present in human
LES circular smooth muscle.
Since LES tone may be maintained by
the activity of a secreted PLA2, we have
used sPLA2-induced contraction as a pos-
sible model of tone. We find that contrac-
tion induced by sPLA2 is mediated by the
same signal transduction pathway that is
active in maintenance ofLES tone. In con-
trol LES, sPLA2-induced contraction is
reduced by the same inhibitors that affect
LES tone of in vitro circular muscle strips.
D609 (PC-PLC inhibitor), U73122 (Pl-
PLC inhibitor), and chelerythrine (PKC
inhibitor) reduces both LES tone and
sPLA2-induced contraction [21, 53], sup-
porting the view that sPLA2-induced con-
traction, like "spontaneous" LES tone,
depends on the activity of PI-PLC, PC-162 Harnett et al.: Signal transduction in LES and esophagus
PLC, resulting in contraction through a
PKC-dependent pathway.
ACH-INDUCED LES CONTRACTION
IN NORMAL ANIMALS
In contrast to spontaneous tone, con-
traction induced by maximally effective
doses of the cholinergic neurotransmitter
acetylcholine is mediated through mus-
carinic M3 receptors, linked to pertussis
toxin-insensitive GTP-binding proteins of
the Gq/i1 type. They activate phospholi-
pase C, which hydrolyzes PIP2, producing
IP3 and DAG. 1P3 causes release of intra-
cellular Ca++ and formation of a Ca"-
calmodulin complex, resulting in activa-
tion ofmyosin light chain kinase and con-
traction through a calmodulin-dependent
pathway (Figure 4) [53].
Thus, unlike LES tone, which is asso-
ciated with spontaneous, submaximal
phospholipase C activity and activation of
a PKC,-dependent pathway, maximal
cholinergic stimulation activates a calmod-
ulin-dependent pathway. The mechanisms
responsible for the switch from a PKC-
dependent to a calmodulin-dependent
pathway are not entirely clear. They may
resultfromthedifferent Ca++requirements
ofcalmodulin and PKC. LowerCa++ levels
are required for PKC activation than for
calmodulin activation [4, 5, 53]. For
instance, relatively low (180 nmolIL)
cytosolic Ca++ levels can support contrac-
tion induced by the PKC agonist DAG, but
contraction induced by calmodulin
requires Ca++ levels approaching 1 gmol/L
[73-78]. In addition, when Ca++ levels are
sufficiently elevated to activate calmod-
ulin, calmodulin may inhibit PKC. The
mechanism of calmodulin-induced inhibi-
tion of PKC activity has not been exten-
sively investigated. Kruger et al. [76]
examined tryptic fragments of calmodulin
and found that two PKC inhibitory
sequences were localized to the first and
third Ca++ binding domains ofcalmodulin,
and that calmodulin-induced PKC inhibi-
tion was not affected by calmodulin antag-
onists. Thus it is possible that, at Ca++ lev-
els insufficient to activate calmodulin, con-
traction will be PKC-dependent. In con-
trast, at Ca++ levels sufficient to fully acti-
vate calmodulin, the contraction will be
calmodulin-dependent, and PKC activity
will be inhibited [79].
The inhibitory role of calmodulin on
PKC-induced contraction is relevant in
order to understand the switch in signal
transduction pathways that occurs in an
experimental model of acute esophagitis
(AE) [5].
ACH-INDUCED LES CONTRACTION
IN ACUTE AND CHRONIC MODELS
OF ESOPHAGITIS
Acute esophagitis
Repeated perfusion of the esophageal
lumen with 0.1 N hydrochloric acid for
three to four days causes a reduction in
resting in vivo LES pressure, in sponta-
neous in vitro tone, in levels ofIP3, and in
releasable intracellular Ca++ stores [1, 2,
4].
We have discussed how contraction of
normal LES smooth muscle in response to
a maximally effective dose of ACh acti-
vates M3 muscarinic receptors, which are
coupled to Gq/11 type G-proteins, linked
to PI-PLC. Activation ofPI-PLC produces
DAG and IP3, which causes release of
Ca++ from intracellular stores, activation
of calmodulin and contraction by a
calmodulin-dependent pathway. AE caus-
es a shift in the intracellular pathway
mediating the response to a maximally
effective dose ofACh from a calmodulin-
dependent to a PKC-dependent pathway
(Figure 5) [5]. After AE, contraction
induced by a maximally effective dose of
ACh is mediated through M2 muscarinic
receptors, linked to Gi3-type G proteins,
which activate phosphatidylcholine-
dependent phospholipase C and phospho-
lipase D to produce DAG. This ACh-
induced contraction depends on influx of
extracellular Ca" which is insufficient toHarnett et al.: Signal transduction in LES and esophagus 163
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Figure 5. Acute esophagitis (AE) modifies ACh signaling in LES circular smooth
muscle. After induction of AE, intracellular Ca++ stores are functionally damaged ordeplet-
ed [4], basal and ACh-induced phosphatidylinositol bisphosphate (PIP2) hydrolysis are
substantially reduced [2, 5], and the resulting reduction in IP3 and intracellular Ca++ release
is insufficient to activate calmodulin (CAM), and inhibit PKC. The signal transduction path-
way mediating contraction in response to ACh, thus switches to a PKC-dependent path-
way, activated by M2 muscarinic receptors linked to G3 PC-PLC and PLD resulting in
hydrolysis of phosphatidylcholine (PC), production of 6AG and activation of PKCi [5].
Influx of extracellular Ca++ is required to activate PC-PLC and PLD. These changes are
reproduced in normal cells by thapsigargin-induced depletion of Ca++ stores.
activate calmodulin, resulting in a PKC-
dependent contraction [2, 4, 8].
These changes in the functional signal
transduction pathway are mimicked in
normal LES muscle by acute depletion of
intracellular Ca++ stores by thapsigargin
[5]. They are, therefore, related to
impaired release ofCa++from intracellular
stores, which arises both from impaired
production of 1P3 [2] and from depletion
ofreleasable Ca++ stores [4] subsequent to
induction of AE. Because release of Ca++
from intracellular stores is reduced in AE,
the available Ca++, which arises mostly
from Ca++ influx, may be insufficient to
activate calmodulin, and, thus, a PKC-
dependent pathway is "unmasked" that
would otherwise be suppressed by
calmodulin activation. A reduction in Ca++
release by inflammation, secondary toAE,
may be the central event, from which all
other observed changes follow, and may
also explain the reduction in resting tone
associated with AE.
Chronic esophagitis
The significance of the subchronic
changes in cat acute esophagitis to the
understanding of esophagitis in humans,
where gastroesophageal reflux disease
(GERD) is likely to develop over a longer
time period, remains to be established.
However, in CE, we find similar but less
accentuated, endoscopic, histologic and
functional changes, up to four to six
months after surgery [8]. The magnitude164 Harnett et al.: Signal transduction in LES and esophagus
of the changes may be related to the
degree ofdamage caused by repeated acid
perfusion, as the degree of damage in the
acute model (45-min acid perfusion x 3
days) is greater than the damage induced
by spontaneous reflux in the chronic
model. In addition, in the chronic model,
the suppression of HCI secretion, either
after the onset ofmild chronic esophagitis,
or at the time ofmyotomy, reverses or pre-
vents the changes in smooth muscle signal
transduction, presumably by inhibiting or
preventing the injury caused by reflux [8].
LESTONE IN ACUTE ESOPHAGITIS
Acute esophagitis causes a decrease
of in vivo and in vitro resting LES tone.
The decrease in tone may be explained by
the same mechanisms that affect the signal
transduction pathway activated by ACh.
In normal LES, resting tone depends
on activity ofPI-PLC, resulting in equimo-
lar formation of 1P3 and DAG. Additional
DAG is produced by activity of PC PLC.
IP3-induced Ca++ release potentiates
DAG-induced activation ofthe Ca++ sensi-
tive PKC,B, responsible for maintenance of
tone. Since AE reduces IP3 formation by
PI-PLC the associated DAG production is
also decreased, resulting in a decrease of
total DAG. In addition, AE causes deple-
tion of Ca++ stores, thus Ca++ release and
DAG formation are substantially
decreased, resulting in reduced activation
of PKCi and reduced LES tone.
CONCLUSION
We conclude that in esophageal circu-
lar muscle ACh-induced contraction, is
mediated by M2 muscarinic receptors,
linked to GO3, PC-PLC, PLD, and cPLA2,
resulting in production of DAG and AA
and activation of the Ca++-insensitive
PKCe. In this contractile pathway Ca++ is
required for activation of the phospholi-
pases and production of the second mes-
sengers DAG and AA, as PKCE is Ca++-
independent and DAG causes contraction
of esophageal muscle cells even in the
absence of Ca++.
Inflammation causes activation of a
second PLA2, which is a group I sPLA2.
This PLA2 causes additional production of
AA, which is metabolized to leukotrienes,
resulting in increased levels of LTs in the
basal state and in response toACh. LT for-
mation in response to ACh contributes to
contraction of esophageal muscle, which
remains ofnormal amplitude, when direct-
ly exposed to ACh. Inflammation causes a
reduction in contraction in response to
neural stimulation, most likely due to
reduced neurotransmitter release sec-
ondary to inflammation. These results are
mimicked by exposing normal esophageal
muscle strips to the pro-inflammatory
cytokines IL-I, and IL-6.
In normal LES smooth muscle cells,
ACh-induced contraction is mediated by
M3 receptors linked to Gq/11 and PI-PLC,
causing formation of IP3, release of Ca++
from stores and activation of calmodulin.
This results in inhibition of PKC and acti-
vation of a calmodulin-dependent contrac-
tile pathway. InAE, releasable Ca++ stores
and IP3 formation are reduced, resulting in
reduced Ca++ release in response to ACh
and dependence on Ca++ influx for con-
traction. The reduced Ca++ release pre-
vents activation of calmodulin and pre-
vents the calmodulin-induced inhibition of
a PKC-dependent pathway, which is not
activated in the normal LES. Thus AE
causes a switch in contractile pathways,
from a calmodulin-dependent to a PKC-
dependent contraction. This switch is
mimicked by thapsigargin-induced deple-
tion ofCa++ stores in normal LES muscle.
The reduction in Ca++ release may
also account for the reduction of in vivo
and in vitro LES resting tone associated
with AE [1, 2, 49].
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